Capital Impact Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

Capital Impact Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 16, 2024	BUY	$14.62 - $18.42 $217,165 - $273,610	14,854 Added 153.36%	24,540 $398,000
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $201,856 - $324,190	-9,686 Reduced 50.0%	9,686 $201,000
Q1 2023 May 23, 2023	BUY	$16.32 - $20.92 $18,931 - $24,267	1,160 Added 6.37%	19,372 $364,000
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $40,356 - $52,946	-2,842 Reduced 13.5%	18,212 $289,000
Q3 2022 Nov 21, 2022	SELL	$14.11 - $18.27 $162,871 - $210,890	-11,543 Reduced 35.41%	21,054 $315,000
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $47,395 - $99,162	3,643 Added 12.58%	32,597 $459,000
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $144,046 - $189,172	6,879 Added 31.16%	28,954 $701,000
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $370,639 - $598,011	22,075 New	22,075 $515,000

279

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.76B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.